Cargando…

Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis

BACKGROUND: Urticarial vasculitis is a small vessel vasculitis characterized by long-lasting wheals. It was suggested omalizumab is well tolerated and effective in patients with hypocomplementaemic urticarial vasculitis. OBJECTIVE: To evaluate the clinical response and safety of omalizumab for treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Taoming, Bai, Juan, Ying, Shuni, Li, Sheng, Pan, Yunlei, Fang, Deren, Qiao, Jianjun, Fang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080115/ https://www.ncbi.nlm.nih.gov/pubmed/33935505 http://dx.doi.org/10.2147/JAA.S304099

Ejemplares similares

Normocomplementemic Urticarial Vasculitis: An Unusual Presentation
por: Manappallil, Robin George, et al.
Publicado: (2020)

Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature
por: Degirmentepe, Ece Nur, et al.
Publicado: (2019)

Normocomplementemic Urticarial Vasculitis Associated with A/H1N1 in a Child. Case Report
por: Gökçe, Şule, et al.
Publicado: (2020)

Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab
por: de Brito, Marianne, et al.
Publicado: (2018)

Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015)

Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2018)

Urticarial vasculitis
por: Gu, Stephanie L., et al.
Publicado: (2021)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

Telmisartan induced urticarial vasculitis
por: Mahajan, Vikram K., et al.
Publicado: (2015)

Neonatal hypocomplementemic urticarial vasculitis
por: Moezinia, Carine J, et al.
Publicado: (2021)

Urticarial Vasculitis Associated With Levothyroxine
por: Metry, Mark, et al.
Publicado: (2023)

Hypocomplementemic urticarial vasculitis syndrome: a look beyond urticarial lesions
por: Pereira, Helena Pires, et al.
Publicado: (2023)

Effectiveness of Dupilumab for an Elderly Patient with Prurigo Nodularis Who Was Refractory and Contradicted to Traditional Therapy
por: Liu, Taoming, et al.
Publicado: (2021)

Urticarial Vasculitis in a Teenage Girl
por: McGuffin, Aaron, et al.
Publicado: (2013)

Urticarial Vasculitis-Associated Intestinal Ischemia
por: Wong, Uni, et al.
Publicado: (2016)

Acquired Haemophilia Associated with Urticarial Vasculitis
por: Attout, Hassene
Publicado: (2020)

Elasomeran: Urticarial vasculitis: case report
Publicado: (2022)

Hypocomplementemic Urticarial Vasculitis in Systemic Lupus Erythematosus
por: Her, Min Young, et al.
Publicado: (2009)

Plasmapheresis in a Patient With "Refractory" Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

A Young Man With Gravitational Urticarial Vasculitis
por: Sadeghinia, Ali, et al.
Publicado: (2020)

AZD-1222: Urticarial vasculitis: case report
Publicado: (2022)

Levetiracetam Induced Urticarial Vasculitis: A Preliminary Report
por: Mangal, Sonia S, et al.
Publicado: (2014)

468 Urticarial Vasculitis After Bee-sting Therapy
por: Lee, June-Hyuk, et al.
Publicado: (2012)

587 Plasmapheresis in a Patient with “Refractory” Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

Management of urticarial vasculitis: A worldwide physician perspective()
por: Kolkhir, Pavel, et al.
Publicado: (2020)

Clinical characteristics and treatment outcomes in patients with urticarial vasculitis
por: Serarslan, Gamze, et al.
Publicado: (2020)

Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis
por: Corthier, Alice, et al.
Publicado: (2022)

Urticarial vasculitis in a young woman with Graves hyperthyroidism
por: Hung, Yi-Teng, et al.
Publicado: (2022)

Urticarial vasculitis: A Complication of SMZ‐TMP therapy
por: Bhasin, Arveen K., et al.
Publicado: (2021)

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
por: Liu, Taoming, et al.
Publicado: (2020)

Infección por COVID-19 en una paciente con síndrome urticarial hipocomplementémico y vasculitis ANCA MPO en hemodiálisis tratada con omalizumab
por: Baldallo, Cinthia, et al.
Publicado: (2021)

Urticarial Vasculitis in Northern Spain: Clinical Study of 21 Cases
por: Loricera, Javier, et al.
Publicado: (2014)

Normocomplementaemic Urticarial Vasculitis in a 19-Month-Old Girl
por: Williams, Peter
Publicado: (2016)

Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
por: Polat, Asude Kara, et al.
Publicado: (2017)

Hypocomplementemic Urticarial Vasculitis Syndrome with Membranous Nephropathy: Case Report
por: Jung, Su Woong, et al.
Publicado: (2017)

Autoimmune thyroid disease and urticarial vasculitis: is there a significant association?
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2019)

Development of a clinical-dermoscopic model for the diagnosis of urticarial vasculitis
por: García-García, B., et al.
Publicado: (2020)

M275 COVID-19 VACCINE RELATED URTICARIAL VASCULITIS
por: Bhatti, S., et al.
Publicado: (2021)

Hypocomplementemic Urticarial Vasculitis Syndrome or Systemic Lupus Erythematosus in Evolution?
por: Kesarwani, Vartika, et al.
Publicado: (2022)

Efficacy of Omalizumab in Indolent Systemic Mastocytosis
por: Slapnicar, Calum, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hs33vva0em7807uhe64totgund